Physician profile
William S Velasquez
NPI 1346201175
$219,246.39
in general payments reported to CMS, 2019-2025
85 companies · $12K in 2025
The $12K reported for 2025 was more than what 89% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115K · 2020: $27K · 2021: $16K · 2022: $30K · 2023: $8,837 · 2024: $10K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Consulting Fee: $14K · Travel and Lodging: $405 · Education: $363 · Grant: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,534.11 |
| Consulting Fee | $14,250.50 |
| Travel and Lodging | $405.30 |
| Education | $363.01 |
| Grant | $235.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $63,594.55 | 2019-2025 | Darzalex, Carvykti, Talvey |
| Celgene Corporation | $36,942.12 | 2019-2025 | Pomalyst, Reblozyl, Opdualag |
| Amgen INC. | $32,811.10 | 2019-2023 | Kyprolis, Xgeva, Vectibix |
| E.R. Squibb & Sons, L.L.C. | $21,592.98 | 2019-2025 | Opdivo, Opdualag, Reblozyl |
| Ipsen Biopharmaceuticals, INC | $9,667.87 | 2019-2024 | Onivyde, Somatuline Depot |
| Coherus Oncology, INC. | $5,779.32 | 2021 | |
| Karyopharm Therapeutics INC. | $5,550.33 | 2024-2025 | Xpovio |
| Seagen INC. | $5,527.18 | 2019-2023 | Padcev |
| Astrazeneca Pharmaceuticals Lp | $4,447.13 | 2020-2025 | Imfinzi, Enhertu, Calquence |
| Gilead Sciences, INC. | $3,404.34 | 2019-2024 | |
| Glaxosmithkline, LLC. | $3,362.30 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Cti Biopharma Corp. | $3,160.57 | 2022-2023 | Vonjo |
| Genentech USA, INC. | $2,955.11 | 2019-2025 | Tecentriq, Polivy, Lunsumio |
| Exelixis INC. | $2,756.96 | 2019-2025 | Cabometyx |
| Janssen Scientific Affairs, LLC | $2,385.66 | 2019 |
Show all 85 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,739.98 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,525.88 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Pfizer INC. | $1,045.60 | 2019-2025 | |
| Genzyme Corporation | $661.49 | 2019-2024 | |
| Incyte Corporation | $660.94 | 2020-2025 | Monjuvi, Monjuvi, Jakafi |
| Abbvie INC. | $611.77 | 2022-2025 | Venclexta |
| Pharmacyclics LLC, An Abbvie Company | $556.19 | 2019-2023 | Imbruvica, Epkinly |
| Lilly USA, LLC | $490.46 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Eisai INC. | $490.24 | 2019-2025 | |
| Astellas Pharma US INC | $483.13 | 2019-2025 | Vyloy, Padcev, Xtandi |
| Takeda Pharmaceuticals U.S.A., INC. | $438.12 | 2019-2025 | Iclusig, Fruzaqla, Alunbrig |
| Beigene USA, INC. | $415.05 | 2020-2025 | Brukinsa |
| Kite Pharma, INC. | $376.12 | 2020-2025 | Yescarta |
| Jazz Pharmaceuticals INC. | $354.15 | 2023-2025 | |
| Daiichi Sankyo INC. | $307.73 | 2021-2025 | Enhertu, Vanflyta |
| Sobi, INC | $283.54 | 2022-2025 | |
| Rigel Pharmaceuticals, INC. | $275.31 | 2020-2025 | Rezlidhia, Tavalisse, Gavreto |
| Regeneron Healthcare Solutions, INC. | $271.73 | 2019-2024 | Libtayo |
| Tersera Therapeutics LLC | $265.62 | 2024-2025 | Xermelo, Zoladex, Quzyttir |
| Array Biopharma INC | $261.80 | 2020-2025 | Braftovi, Mektovi, Tukysa |
| Springworks Therapeutics, INC. | $246.44 | 2024-2025 | Ogsiveo |
| Bayer Healthcare Pharmaceuticals INC. | $239.88 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $223.18 | 2019-2022 | |
| Stemline Therapeutics INC. | $216.81 | 2023-2025 | Orserdu |
| Recordati_rare_diseases_inc. | $179.68 | 2025 | Sylvant, Enjaymo |
| Adaptive Biotechnologies Corporation | $177.65 | 2021-2025 | Clonoseq |
| Deciphera Pharmaceuticals INC. | $172.97 | 2022-2025 | Qinlock, Romvimza |
| Taiho Oncology, INC. | $171.47 | 2019-2021 | |
| Boston Scientific Corporation | $162.45 | 2022-2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Eusa Pharma (US) LLC | $132.96 | 2020 | |
| Sirtex Medical INC | $127.66 | 2023-2024 | Sir-Spheres Microspheres |
| Nestle Healthcare Nutrition INC. | $122.85 | 2023 | |
| Blueprint Medicines Corporation | $117.85 | 2020-2025 | Ayvakit |
| Beone Medicines USA, INC. | $84.70 | 2025 | Brukinsa |
| Secura Bio, INC. | $83.04 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $79.44 | 2022-2024 | Myrisk |
| Agios Pharmaceuticals, INC. | $74.86 | 2019-2022 | |
| Tempus Ai, INC | $68.03 | 2024-2025 | Xt Cdx |
| Adc Therapeutics America, INC. | $64.44 | 2022-2024 | |
| Emd Serono, INC. | $63.00 | 2021-2022 | |
| Puma Biotechnology, INC. | $58.15 | 2019-2024 | |
| Pharmaessentia USA Corporation | $56.09 | 2024 | Besremi |
| Pharming Healthcare, INC. | $55.26 | 2022-2024 | Ruconest |
| Syndax Pharmaceuticals, INC. | $52.56 | 2025 | |
| Tg Therapeutics, INC. | $50.05 | 2021 | |
| Acrotech Biopharma INC. | $47.88 | 2021 | |
| Pharmacosmos Therapeutics INC. | $47.29 | 2020-2025 | Monoferric |
| Servier Pharmaceuticals LLC | $46.75 | 2022 | |
| Kyowa Kirin, INC. | $45.34 | 2023 | Poteligeo |
| Genmab U.S., INC. | $37.61 | 2024-2025 | Epkinly |
| Aveo Pharmaceuticals, INC. | $36.21 | 2022-2023 | Fotivda |
| Aurobindo Pharma USA, INC. | $35.85 | 2020 | |
| Mirati Therapeutics, INC. | $34.04 | 2023-2024 | Krazati |
| Geron Corporation | $30.86 | 2025 | Rytelo |
| Clarus Therapeutics INC. | $27.38 | 2021 | |
| Amneal Pharmaceuticals LLC | $26.19 | 2024 | Avastin, Neupogen, Neulasta |
| Alexion Pharmaceuticals, INC. | $24.55 | 2023 | Ultomiris |
| Iovance Biotherapeutics, INC. | $24.53 | 2025 | Amtagvi |
| Clovis Oncology, INC. | $23.71 | 2019 | |
| Dova Pharmaceuticals | $23.19 | 2021 | |
| Urogen Pharma, INC. | $22.60 | 2024 | |
| Verity Pharmaceuticals INC. | $21.63 | 2022 | |
| Sumitomo Pharma America, INC. | $21.58 | 2023 | Orgovyx |
| Azurity Pharmaceuticals, INC. | $21.47 | 2025 | Danziten |
| Mylan Institutional INC. | $21.46 | 2019 | |
| Octapharma USA, INC. | $20.95 | 2019 | |
| Tesaro, INC. | $20.60 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $18.75 | 2019 | |
| Medtronic USA, INC. | $17.54 | 2019 | |
| Stimwave Technologies Incorporated | $14.59 | 2019 |
Drugs and devices associated with these payments
Darzalex $6,379Carvykti $5,997Xpovio $5,781Talvey $4,448Tecvayli $3,283Imbruvica $1,280Keytruda $941Opdivo $849Pomalyst $490Enhertu $430Opdualag $420Ojjaara $395Brukinsa $385Lenvima $371Vonjo $365Lynparza $356Jemperli $346Elahere $324Tukysa $305Cabometyx $293Monjuvi $281Xtandi $280Zepzelca $272Reblozyl $271Ibrance $243Kisqali $223Orserdu $217Yescarta $210Ogsiveo $209Enjaymo $209Talzenna $194Scemblix $193Imfinzi $179Fabhalta $178Zejula $178Epkinly $174Tavalisse $172Rezlidhia $172Sarclisa $170Tecentriq $169Padcev $168Venclexta $157Qinlock $151Verzenio $146Therasphere Y90 Glass Microspheres 10 Gbq $143Inlyta $141Stivarga $141Braftovi $139Mektovi $139Jaypirca $132Sir-Spheres Microspheres $128Libtayo $127Sylvant $125Zenpep $123Jakafi $121Vitrakvi $117Xermelo $116Zoladex $112Clonoseq $109Polivy $109Mekinist $109Rybrevant $106Lunsumio $103Iclusig $102Retevmo $102Bexsero $102Orgovyx $97.24Elrexfio $96.56Adcetris $96.56Vyloy $93.39Ayvakit $83.64Fruzaqla $76.28Promacta $75.11Keytruda Qlex $70.48Erleada $69.45Comirnaty $63.18Phesgo $59.14Nubeqa $58.72Kyprolis $58.30Besremi $56.09Columvi $54.96Paxlovid $54.58Gavreto $54.46Pluvicto $51.65Xt Cdx $51.16Emrelis $49.62Welireg $48.18Calquence $46.33Poteligeo $45.34Shingrix $42.45Alecensa $41.61Xgeva $39.47Nplate $39.47Vectibix $39.47Bosulif $38.75Besponsa $38.75Quzyttir $38.24Romvimza $36.79Lorbrena $36.65Ziihera $35.62
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Velasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.